Literature DB >> 24976513

Adenosine A₁ receptors in mouse pontine reticular formation modulate nociception only in the presence of systemic leptin.

S L Watson1, C J Watson1, H A Baghdoyan1, R Lydic2.   

Abstract

Human obesity is associated with increased leptin levels and pain, but the specific brain regions and neurochemical mechanisms underlying this association remain poorly understood. This study used adult male C57BL/6J (B6, n=14) mice and leptin-deficient, obese B6.Cg-Lep(ob)/J (obese, n=10) mice to evaluate the hypothesis that nociception is altered by systemic leptin levels and by adenosine A₁ receptors in the pontine reticular formation. Nociception was quantified as paw withdrawal latency (PWL) in s after onset of a thermal stimulus. PWL was converted to percent maximum possible effect (%MPE). After obtaining baseline PWL measures, the pontine reticular formation was microinjected with saline (control), three concentrations of the adenosine A₁ receptor agonist N(6)-p-sulfophenyladenosine (SPA), or super-active mouse leptin receptor antagonist (SMLA) followed by SPA 15 min later, and PWL was again quantified. In obese, leptin-deficient mice, nociception was quantified before and during leptin replacement via subcutaneous osmotic pumps. SPA was administered into the pontine reticular formation of leptin-replaced mice and PWL testing was repeated. During baseline (before vehicle or SPA administration), PWL was significantly (p=0.0013) lower in leptin-replaced obese mice than in B6 mice. Microinjecting SPA into the pontine reticular formation of B6 mice caused a significant (p=0.0003) concentration-dependent increase in %MPE. SPA also significantly (p<0.05) increased %MPE in B6 mice and in leptin-replaced obese mice, but not in leptin-deficient obese mice. Microinjection of SMLA into the pontine reticular formation before SPA did not alter PWL. The results show for the first time that pontine reticular formation administration of the adenosine A₁ receptor agonist SPA produced antinociception only in the presence of systemic leptin. The concentration-response data support the interpretation that adenosine A₁ receptors localized to the pontine reticular formation significantly alter nociception.
Copyright © 2014 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  adenosine A(1) receptors; leptin-deficient; obesity; pain

Mesh:

Substances:

Year:  2014        PMID: 24976513      PMCID: PMC4143377          DOI: 10.1016/j.neuroscience.2014.06.025

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  50 in total

1.  Leptin prevents respiratory depression in obesity.

Authors:  C P O'donnell; C D Schaub; A S Haines; D E Berkowitz; C G Tankersley; A R Schwartz; P L Smith
Journal:  Am J Respir Crit Care Med       Date:  1999-05       Impact factor: 21.405

Review 2.  Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity.

Authors:  Ashwini Oswal; Giles Yeo
Journal:  Obesity (Silver Spring)       Date:  2009-07-30       Impact factor: 5.002

3.  Effects of leptin on pedunculopontine nucleus (PPN) neurons.

Authors:  Paige Beck; Francisco J Urbano; D Keith Williams; Edgar Garcia-Rill
Journal:  J Neural Transm (Vienna)       Date:  2012-12-21       Impact factor: 3.575

4.  Impact of sleep debt on metabolic and endocrine function.

Authors:  K Spiegel; R Leproult; E Van Cauter
Journal:  Lancet       Date:  1999-10-23       Impact factor: 79.321

5.  Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice.

Authors:  Raul M Luque; Zhi H Huang; Bhumik Shah; Theodore Mazzone; Rhonda D Kineman
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-11-22       Impact factor: 4.310

6.  Cholinomimetics, but not morphine, increase antinociceptive behavior from pontine reticular regions regulating rapid-eye-movement sleep.

Authors:  A M Kshatri; H A Baghdoyan; R Lydic
Journal:  Sleep       Date:  1998-11-01       Impact factor: 5.849

7.  Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, and Activity Promotion Trial.

Authors:  Stephen P Messier; Richard F Loeser; Gary D Miller; Timothy M Morgan; W Jack Rejeski; Mary Ann Sevick; Walter H Ettinger; Marco Pahor; Jeff D Williamson
Journal:  Arthritis Rheum       Date:  2004-05

8.  Incidence of childhood obesity in the United States.

Authors:  Solveig A Cunningham; Michael R Kramer; K M Venkat Narayan
Journal:  N Engl J Med       Date:  2014-01-30       Impact factor: 91.245

Review 9.  Development of leptin antagonists and their potential use in experimental biology and medicine.

Authors:  Arieh Gertler
Journal:  Trends Endocrinol Metab       Date:  2006-09-28       Impact factor: 12.015

10.  Impact of 5-year weight change on blood pressure: results from the Weight Loss Maintenance trial.

Authors:  Crystal C Tyson; Lawrence J Appel; William M Vollmer; Gerald J Jerome; Phillip J Brantley; Jack F Hollis; Victor J Stevens; Jamy D Ard; Uptal D Patel; Laura P Svetkey
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-04-11       Impact factor: 3.738

View more
  3 in total

1.  Buprenorphine Depresses Respiratory Variability in Obese Mice with Altered Leptin Signaling.

Authors:  Chelsea Angel; Zachary T Glovak; Wateen Alami; Sara Mihalko; Josh Price; Yandong Jiang; Helen A Baghdoyan; Ralph Lydic
Journal:  Anesthesiology       Date:  2018-05       Impact factor: 7.892

2.  Leptin status alters buprenorphine-induced antinociception in obese mice with dysfunctional leptin receptors.

Authors:  Zachary Glovak; Sara Mihalko; Helen A Baghdoyan; Ralph Lydic
Journal:  Neurosci Lett       Date:  2017-09-08       Impact factor: 3.046

3.  Reduced intraepidermal nerve fiber density after a sustained increase in insular glutamate: a proof-of-concept study examining the pathogenesis of small fiber pathology in fibromyalgia.

Authors:  Steven E Harte; Daniel J Clauw; John M Hayes; Eva L Feldman; Irene C St Charles; Christopher J Watson
Journal:  Pain Rep       Date:  2017-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.